3-thia-4-arylquinolin-2-one derivatives

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S155000

Reexamination Certificate

active

10964489

ABSTRACT:
This invention describes compounds of Formula (I) which are modulators of potassium channels and are useful for treating conditions affected by abnormal potassium channel activity including erectile dysfunction and irritable bowel syndrome

REFERENCES:
patent: 5892045 (1999-04-01), Sit et al.
patent: 5922735 (1999-07-01), Sit et al.
patent: 5972961 (1999-10-01), Hewawasam et al.
patent: 6184231 (2001-02-01), Hewawasam et al.
patent: 6353119 (2002-03-01), Crispino et al.
patent: 6538022 (2003-03-01), Pollesello et al.
patent: 7049309 (2006-05-01), Boy et al.
patent: 2002371078 (2002-12-01), None
patent: WO 02/26713 (2002-04-01), None
P. Hewawasam, et al, “4-Aryl-3-(Hydroxyalkyl)Quinolin-2-Ones: Novel Maxi-K Channel Opening Relaxants of Corporal Smooth Muscle Targeted for Erectile Dysfunction,” J. Med. Chem., 46, pp. 2819-2822, 2003.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-thia-4-arylquinolin-2-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-thia-4-arylquinolin-2-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-thia-4-arylquinolin-2-one derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3829925

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.